🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/12/2005 | 28,27 | 28,63 | 28,26 | 28,60 | +0,98% | 1,28% | 7.269.242 |
| 01/12/2005 | 28,33 | 28,50 | 28,01 | 28,32 | +0,95% | 1,75% | 10.056.503 |
| 30/11/2005 | 28,38 | 28,58 | 28,02 | 28,05 | -2,07% | 1,95% | 10.843.027 |
| 29/11/2005 | 28,24 | 28,92 | 28,24 | 28,65 | +1,56% | 2,40% | 17.992.483 |
| 28/11/2005 | 29,59 | 29,59 | 27,95 | 28,21 | -4,58% | 5,55% | 27.461.792 |
| 25/11/2005 | 29,39 | 29,59 | 29,26 | 29,56 | +0,55% | 1,14% | 3.651.756 |
| 23/11/2005 | 29,20 | 29,46 | 29,02 | 29,40 | +0,98% | 1,50% | 6.040.358 |
| 22/11/2005 | 29,08 | 29,24 | 28,88 | 29,11 | +0,13% | 1,21% | 6.962.074 |
| 21/11/2005 | 29,02 | 29,14 | 28,80 | 29,07 | +0,16% | 1,18% | 8.207.936 |
| 18/11/2005 | 28,55 | 29,06 | 28,29 | 29,03 | +2,74% | 2,67% | 14.275.018 |
| 17/11/2005 | 28,62 | 28,65 | 28,17 | 28,25 | -0,57% | 1,67% | 7.814.936 |
| 16/11/2005 | 28,73 | 28,86 | 28,23 | 28,42 | -0,80% | 2,19% | 8.666.122 |
| 15/11/2005 | 28,82 | 28,97 | 28,57 | 28,65 | -0,69% | 1,39% | 10.513.117 |
| 14/11/2005 | 28,63 | 28,86 | 28,60 | 28,85 | +0,67% | 0,90% | 8.825.732 |
| 11/11/2005 | 28,70 | 28,70 | 28,23 | 28,65 | +0,00% | 1,66% | 9.074.213 |
| 10/11/2005 | 28,34 | 28,72 | 28,23 | 28,65 | +1,49% | 1,72% | 8.638.664 |
| 09/11/2005 | 27,81 | 28,36 | 27,81 | 28,23 | +0,75% | 1,96% | 6.838.619 |
| 08/11/2005 | 28,13 | 28,46 | 28,00 | 28,02 | -0,27% | 1,66% | 7.065.616 |
| 07/11/2005 | 27,88 | 28,11 | 27,67 | 28,10 | +0,79% | 1,57% | 5.985.966 |
| 04/11/2005 | 28,05 | 28,15 | 27,68 | 27,88 | -0,88% | 1,67% | 10.239.484 |
| 03/11/2005 | 27,15 | 29,48 | 27,09 | 28,13 | +3,77% | 8,82% | 39.939.804 |
| 02/11/2005 | 26,95 | 27,16 | 26,53 | 27,11 | -0,39% | 2,34% | 10.095.594 |
| 01/11/2005 | 27,15 | 27,33 | 26,91 | 27,21 | +1,06% | 1,55% | 12.250.282 |
| 31/10/2005 | 26,46 | 26,97 | 26,38 | 26,93 | +2,47% | 2,20% | 13.286.230 |
| 28/10/2005 | 26,13 | 26,31 | 25,95 | 26,28 | +2,30% | 1,35% | 10.931.583 |
| 27/10/2005 | 25,77 | 25,94 | 25,69 | 25,69 | -0,99% | 1,00% | 6.727.531 |
| 26/10/2005 | 25,69 | 26,00 | 25,68 | 25,94 | +0,63% | 1,26% | 7.129.544 |
| 25/10/2005 | 25,52 | 25,87 | 25,50 | 25,78 | +0,07% | 1,46% | 7.258.343 |
| 24/10/2005 | 25,71 | 25,80 | 24,93 | 25,76 | +3,13% | 3,38% | 10.130.702 |
| 21/10/2005 | 25,69 | 25,81 | 24,93 | 24,98 | -2,75% | 3,42% | 10.009.867 |